These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats. Chen X; Wu S; Tang L; Ma L; Wang F; Feng H; Meng J; Han Z J Cell Physiol; 2019 May; 234(5):7301-7319. PubMed ID: 30362554 [TBL] [Abstract][Full Text] [Related]
43. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment. Muhammad W; Zhu J; Zhai Z; Xie J; Zhou J; Feng X; Feng B; Pan Q; Li S; Venkatesan R; Li P; Cao H; Gao C Acta Biomater; 2022 Aug; 148():258-270. PubMed ID: 35724918 [TBL] [Abstract][Full Text] [Related]
44. RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages. Zhang HW; Wang Q; Mei HX; Zheng SX; Ali AM; Wu QX; Ye Y; Xu HR; Xiang SY; Jin SW Int Immunopharmacol; 2019 Nov; 76():105877. PubMed ID: 31522017 [TBL] [Abstract][Full Text] [Related]
45. Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade. Patangrao Renushe A; Kumar Banothu A; Kumar Bharani K; Mekala L; Mahesh Kumar J; Neeradi D; Durga Veera Hanuman D; Gadige A; Khurana A Int Immunopharmacol; 2022 Jul; 108():108773. PubMed ID: 35453074 [TBL] [Abstract][Full Text] [Related]
46. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291 [TBL] [Abstract][Full Text] [Related]
47. Two indole-2-carboxamide derivatives attenuate lipopolysaccharide-induced acute lung injury by inhibiting inflammatory response. Dai W; Ge X; Xu T; Lu C; Zhou W; Sun D; Gong Y; Dai Y Can J Physiol Pharmacol; 2018 Dec; 96(12):1261-1267. PubMed ID: 30326195 [TBL] [Abstract][Full Text] [Related]
49. Implication of mitochondrial ROS-NLRP3 inflammasome axis during two-hit mediated acute lung injury in mice. Puri G; Naura AS Free Radic Res; 2022 Jan; 56(1):1-16. PubMed ID: 35129032 [TBL] [Abstract][Full Text] [Related]
50. NIR triggered polydopamine coated cerium dioxide nanozyme for ameliorating acute lung injury via enhanced ROS scavenging. Yin M; Lei D; Liu Y; Qin T; Gao H; Lv W; Liu Q; Qin L; Jin W; Chen Y; Liang H; Wang B; Gao M; Zhang J; Lu J J Nanobiotechnology; 2024 Jun; 22(1):321. PubMed ID: 38849841 [TBL] [Abstract][Full Text] [Related]
51. MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice. Gao J; Teng L; Yang S; Huang S; Li L; Zhou L; Liu G; Tang H Biochem Pharmacol; 2021 Apr; 186():114499. PubMed ID: 33675774 [TBL] [Abstract][Full Text] [Related]
52. The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice. Jiang J; Jian Q; Jing M; Zhang Z; Zhang G; Shan L; Yu P; Wang Y; Xu L Int Immunopharmacol; 2019 Jan; 66():109-118. PubMed ID: 30447529 [TBL] [Abstract][Full Text] [Related]
53. Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation. Sun GY; Yang HH; Guan XX; Zhong WJ; Liu YP; Du MY; Luo XQ; Zhou Y; Guan CX Mol Immunol; 2018 May; 97():8-15. PubMed ID: 29544087 [TBL] [Abstract][Full Text] [Related]
54. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193 [TBL] [Abstract][Full Text] [Related]
55. MicroRNA-23a-5p Is Involved in the Regulation of Lipopolysaccharide-Induced Acute Lung Injury by Targeting HSP20/ASK1. Chen YF; Hu F; Wang XG; Tang Z; Tang HX; Xu M Oxid Med Cell Longev; 2021; 2021():9942557. PubMed ID: 34422215 [TBL] [Abstract][Full Text] [Related]
56. Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation. Liu H; Lin Z; Ma Y Biomed Pharmacother; 2020 May; 125():109943. PubMed ID: 32106380 [TBL] [Abstract][Full Text] [Related]
57. The inhibition of GLUT1-induced glycolysis in macrophage by phloretin participates in the protection during acute lung injury. Songyang Y; Li W; Li W; Yang J; Song T Int Immunopharmacol; 2022 Sep; 110():109049. PubMed ID: 35853279 [TBL] [Abstract][Full Text] [Related]
58. Lung epithelial cell-derived IL-25 negatively regulates LPS-induced exosome release from macrophages. Li ZG; Scott MJ; Brzóska T; Sundd P; Li YH; Billiar TR; Wilson MA; Wang P; Fan J Mil Med Res; 2018 Jul; 5(1):24. PubMed ID: 30056803 [TBL] [Abstract][Full Text] [Related]
59. Interleukin-10-Overexpressing Mesenchymal Stromal Cells Induce a Series of Regulatory Effects in the Inflammatory System and Promote the Survival of Endotoxin-Induced Acute Lung Injury in Mice Model. Wang C; Lv D; Zhang X; Ni ZA; Sun X; Zhu C DNA Cell Biol; 2018 Jan; 37(1):53-61. PubMed ID: 29072959 [TBL] [Abstract][Full Text] [Related]
60. Trametinib alleviates lipopolysaccharide-induced acute lung injury by inhibiting the MEK-ERK-Egr-1 pathway. Chen S; Xu H; Ye P; Wu C; Ding X; Chen S; Zhang H; Zou Y; Zhao J; Le S; Wu J; Chen S; Xia J Int Immunopharmacol; 2020 Mar; 80():106152. PubMed ID: 31926447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]